Biotechnology continues to be the hottest thing in the stock market. The leader of the surge is Celgene Corporation (NASDAQ:CELG). The stock is up over 10% in the last week and has momentum to continue higher. The first and only level where investors should expect resistance is $140.00. This is the all-time high on the stock from 2015. For a quick trade, investors can consider a short on Celgene Corporation at this level. See the chart below.